Бабкина Ирина Валентиновна
Russian Cancer Research Center NN Blokhin · 41 works · 97 citations · h-index 6
Top works
- Matrix Metalloproteinases 2, 7, 9 and Tissue Inhibitor of Matrix Metalloproteinase-1 in the Sera of Patients with Bone Tumors
- Vascular endothelium growth factor and angiogenin in the serum of patients with osteosarcoma and Ewing’s tumor
- Receptor Activator of Nuclear Transcription Factor NF-κB (RANK), Its Ligand RANKL, and Natural Inhibitor of RANKL Osteoprotegerin (OPG) in the Blood Serum of Patients with Primary Bone Tumors
- Leptin and apoptosis inhibitor soluble fas antigen in the serum of patients with osteosarcoma and neuroectodermal bone tumors
- Prostaglandins E in primary tumor, metastases, and ascitic fluid of patients with ovarian cancer
- Endostatin, Placental Growth Factor, and Fibroblast Growth Factors-1 and -2 in the Sera of Patients with Primary Osteosarcomas
- Tissue- and Urokinase-Type Plasminogen Activators and Type 1 Plasminogen Activator Inhibitor in Melanomas and Benign Skin Pigment Neoplasms
- CLINICAL ANALYSIS OF SERUM INTERLEUKIN-16 AND VASCULAR ENDOTHELIAL GROWTH FACTOR LEVELS DEPENDING ON MORPHOLOGICAL CHARACTERISTICS OF THE TUMORS AND LONG-TERM TREATMENT OUTCOMES IN PATIENTS WITH BONE NEOPLASMS
- Calmodulin in osteogenic sarcoma
- Features of cell immunity of healthcare workers in the first wave of the SARS-CoV-2 infection pandemic
- Increase in serum concentration of FAS ligand as a possible mechanism for antithyroid cytotoxicity during autoimmune thyroid diseases
- Increase in Serum Concentration of FAS Ligand as a Possible Mechanism for Antithyroid Cytotoxicity during Autoimmune Thyroid Diseases
- Prognostic significance of the TNM system criteria, levels of serum insulin-like growth factors and their transport proteins, VEGF and MMP-7 in colorectal cancer
- Apixaban for the treatment and secondary prevention of thrombotic complications in cancer patients with impaired renal function
- LONG-TERM RESULTS OF TREATING PATIENTS WITH BONE OSTEOSARCOMA TAKING INTO ACCOUNT THE CONTENT OF MATRIX METALLOPROTEINAS AND THEIR TISSUE INHIBITORS IN BLOOD SERUM
- Инсулиноподобные факторы роста и их транспортные белки в прогнозе злокачественных опухолей костей
- Содержание рецептора конечных продуктов гликирования rage и матриксной металлопротеиназы 2 типа в сыворотке крови больных опухолями костей
- Фактор роста эндотелия сосудов в диагностике рака предстательной железы
- Компоненты лиганд-рецепторной системы rank/rankl, интерлейкин-6 и кальцитонин в сыворотке крови при гигантоклеточной опухоли кости
- Soluble forms of programmable cell death receptor sPD-L and ligand sPD-L1, as well as some biochemical and hematological indicators in the blood of COVID-19 diseased